Advanced Search
MyIDEAS: Login to follow this author

Tomas J Philipson

Contents:

This is information that was supplied by Tomas Philipson in registering through RePEc. If you are Tomas J Philipson , you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name: Tomas
Middle Name: J
Last Name: Philipson
Suffix:

RePEc Short-ID: pph37

Email:
Homepage: http://harrisschool.uchicago.edu/faculty/web-pages/tomas-philipson.asp
Postal Address:
Phone:

Affiliation

(in no particular order)

Lists

This author is featured on the following reading lists, publication compilations or Wikipedia entries:
  1. Technology Assessment

Works

as in new window

Working papers

  1. Mark Egan & Tomas J. Philipson, 2014. "Non-Adherence In Health Care: A Positive and Normative Analysis," NBER Working Papers 20330, National Bureau of Economic Research, Inc.
  2. Ralph Koijen & Tomas Philipson & Harald Uhlig, 2014. "Financial Health Economics," NBER Working Papers 20075, National Bureau of Economic Research, Inc.
  3. Tomas J. Philipson & George Zanjani, 2013. "Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension," NBER Working Papers 19005, National Bureau of Economic Research, Inc.
  4. Mark L. Egan & Casey B. Mulligan & Tomas J. Philipson, 2013. "Adjusting National Accounting for Health: Is the Business Cycle Countercyclical?," NBER Working Papers 19058, National Bureau of Economic Research, Inc.
  5. Mark Egan & Tomas J. Philipson, 2013. "International Health Economics," NBER Working Papers 19280, National Bureau of Economic Research, Inc.
  6. Kristopher J. Hult & Tomas J. Philipson, 2012. "Public Liabilities and Health Care Policy," NBER Working Papers 18571, National Bureau of Economic Research, Inc.
  7. Anup Malani & Tomas J. Philipson, 2011. "Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets," NBER Working Papers 17011, National Bureau of Economic Research, Inc.
  8. Anirban Basu & Tomas J. Philipson, 2010. "The Impact of Comparative Effectiveness Research on Health and Health Care Spending," NBER Working Papers 15633, National Bureau of Economic Research, Inc.
  9. Tomas J. Philipson & Gary Becker & Dana Goldman & Kevin M. Murphy, 2010. "Terminal Care and The Value of Life Near Its End," NBER Working Papers 15649, National Bureau of Economic Research, Inc.
  10. Anupam Jena & Tomas Philipson, 2009. "Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption," NBER Working Papers 15032, National Bureau of Economic Research, Inc.
  11. Tomas J. Philipson & Eric C. Sun & Dana Goldman, 2009. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Working Papers 15603, National Bureau of Economic Research, Inc.
  12. Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman, 2009. "An Economic Evaluation of the War on Cancer," NBER Working Papers 15574, National Bureau of Economic Research, Inc.
  13. Tomas Philipson & Richard Posner, 2008. "Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity," NBER Working Papers 14010, National Bureau of Economic Research, Inc.
  14. Anupam Jena & Casey Mulligan & Tomas J. Philipson & Eric Sun, 2008. "The Value of Life in General Equilibrium," NBER Working Papers 14157, National Bureau of Economic Research, Inc.
  15. Gary Becker & Kevin Murphy & Tomas Philipson, 2007. "The Value of Life Near its End and Terminal Care," NBER Working Papers 13333, National Bureau of Economic Research, Inc.
  16. Dana Goldman & Tomas Philipson, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," NBER Working Papers 12870, National Bureau of Economic Research, Inc.
  17. Tomas J. Philipson & Eric Sun, 2007. "Is the Food and Drug Administration Safe and Effective?," NBER Working Papers 13561, National Bureau of Economic Research, Inc.
  18. Tomas Philipson & Stephane Mechoulan & Anupam Jena, 2006. "Health Care, Technological Change, and Altruistic Consumption Externalities," NBER Working Papers 11930, National Bureau of Economic Research, Inc.
  19. Tomas J. Philipson & Anupam B. Jena, 2006. "Surplus Appropriation from R&D and Health Care Technology Assessment Procedures," NBER Working Papers 12016, National Bureau of Economic Research, Inc.
  20. Darius Lakdawalla & Tomas Philipson & Y. Richard Wang, 2006. "Intellectual Property and Marketing," NBER Working Papers 12577, National Bureau of Economic Research, Inc.
  21. Tomas J. Philipson & Anupam B. Jena, 2005. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," NBER Working Papers 11810, National Bureau of Economic Research, Inc.
  22. Tomas J. Philipson & Ernst R. Berndt & Adrian H. B. Gottschalk & Matthew W. Strobeck, 2005. "Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts," NBER Working Papers 11724, National Bureau of Economic Research, Inc.
  23. Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck, 2004. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Working Papers 10822, National Bureau of Economic Research, Inc.
  24. Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares, 2003. "The Quantity and Quality of Life and the Evolution of World Inequality," NBER Working Papers 9765, National Bureau of Economic Research, Inc.
  25. Tomas Philipson & Stephane Mechoulan, 2003. "Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets," NBER Working Papers 9598, National Bureau of Economic Research, Inc.
  26. Frank R. Lichtenberg & Tomas J. Philipson, 2002. "The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the US," Working Papers 0209, Harris School of Public Policy Studies, University of Chicago.
  27. Frank R. Lichtenberg & Tomas J. Philipson, 2002. "The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry," NBER Working Papers 9303, National Bureau of Economic Research, Inc.
  28. Darius Lakdawalla & Tomas Philipson, 2002. "The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination," NBER Working Papers 8946, National Bureau of Economic Research, Inc.
  29. Tomas J. Philipson & Richard A. Posner, 2001. "Antitrust and the Not-For-Profit Sector," NBER Working Papers 8126, National Bureau of Economic Research, Inc.
  30. Tomas J. Philipson, 2000. "External Treatment Effects and Program Implementation Bias," NBER Technical Working Papers 0250, National Bureau of Economic Research, Inc.
  31. Casey B. Mulligan & Tomas J. Philipson, 2000. "Merit Motives and Government Intervention: Public Finance in Reverse," NBER Working Papers 7698, National Bureau of Economic Research, Inc.
  32. Tomas J. Philipson & Richard A. Posner, 1999. "The Long-Run Growth in Obesity as a Function of Technological Change," NBER Working Papers 7423, National Bureau of Economic Research, Inc.
  33. Tomas Philipson, 1999. "Economic Epidemiology and Infectious Diseases," NBER Working Papers 7037, National Bureau of Economic Research, Inc.
  34. Darius Lakdawalla & Tomas Philipson, 1999. "Aging and the Growth of Long-Term Care," NBER Working Papers 6980, National Bureau of Economic Research, Inc.
  35. Thomas Philipson & Darius Lakdawalla, 1998. "The Rise in Old Age Longevity and the Market for Long-Term Care," University of Chicago - George G. Stigler Center for Study of Economy and State 146, Chicago - Center for Study of Economy and State.
  36. Geoffard, P.Y. & Philipson, T., 1998. "Data MArkets and OPtimal Sample Size Determination," DELTA Working Papers 98-15, DELTA (Ecole normale supérieure).
  37. Darius Lakdawalla & Tomas Philipson, 1998. "Nonprofit Production and Competition," NBER Working Papers 6377, National Bureau of Economic Research, Inc.
  38. Geoffard, P.Y. & Philipson, T., 1998. "Pricing and R&D with Related Margins," DELTA Working Papers 98-14, DELTA (Ecole normale supérieure).
  39. Charles Mullin & Tomas Philipson, 1997. "The Future of Old-Age Longevity: Competitive Pricing of Mortality Contingent Claims," NBER Working Papers 6042, National Bureau of Economic Research, Inc.
  40. William H. Dow & Tomas Philipson & Xavier Sala-i-Martin & Jessica Holmes, 1997. "Health investment complementarities under competing risks," Economics Working Papers 192, Department of Economics and Business, Universitat Pompeu Fabra.
  41. Tomas Philipson & George Zanjani, 1997. "Consumption vs. Production of Insurance," NBER Working Papers 6225, National Bureau of Economic Research, Inc.
  42. Tomas Philipson, 1997. "Observational Agency and Supply-Side Econometrics," NBER Technical Working Papers 0210, National Bureau of Economic Research, Inc.
  43. John Cawley & Tomas Philipson, 1997. "An Empirical Examination of Information Barriers to Trade inInsurance," University of Chicago - George G. Stigler Center for Study of Economy and State 132, Chicago - Center for Study of Economy and State.
  44. Tomas Philipson & Gary S. Becker, 1996. "Mortality Contingent Claims, Health Care, and Social Insurance," University of Chicago - George G. Stigler Center for Study of Economy and State 129, Chicago - Center for Study of Economy and State.
  45. Boozer, M. & Philipson, T., 1996. "The Private Demand for Information and the Effects of Public Testing Programs: The Case of HIV," Papers 750, Yale - Economic Growth Center.
  46. Geoffard, P.Y. & Philipson, T., 1995. "Rational Epidemics and their Public Control," DELTA Working Papers 95-15, DELTA (Ecole normale supérieure).
  47. William H. Dow & Jessica Holmes & Tomas Philipson & Xavier Sala-i-Martin, 1995. "Disease Complementarities and the Evaluation of Public Health Interventions," NBER Working Papers 5216, National Bureau of Economic Research, Inc.
  48. William H. Dow & Jessica Holmes & Tomas Philipson & Xavier Sala-i-Martin, 1995. "Death, tetanus, and aerobics: The evaluation of disease-specific health interventions," Economics Working Papers 124, Department of Economics and Business, Universitat Pompeu Fabra.
  49. Geoffard, P.Y. & Philipson, T., 1995. "Disease Eradication: Private vs. Public Vaccination," DELTA Working Papers 95-09, DELTA (Ecole normale supérieure).
  50. Tomas J. Philipson, . "Self-Interested Treatment Evaluation in Experiments," University of Chicago - Population Research Center 95-1, Chicago - Population Research Center.
  51. Larry V. Hedges & Tomas Philipson, . "Is Health Care Technology Over-Approved? A Meta-Analysis of Revealed Preference," University of Chicago - Population Research Center 95-8, Chicago - Population Research Center.
  52. Tomas Philipson & Edward Vytlacil, . "Estimating the Extent of Trade Under Incomplete Information: The Case of HIV," University of Chicago - Population Research Center 94-8, Chicago - Population Research Center.
  53. Avner Ahituv & V. Joseph Hotz & Tomas Philipson, . "Will the AIDS Epidemic be Self-Limiting? Evidence on the Responsiveness of the Demand for Condoms to the Prevalence of AIDS," University of Chicago - Population Research Center 93-3, Chicago - Population Research Center.
  54. Tomas Philipson & Darius Lakdawalla, . "Nonprofit Production," University of Chicago - Population Research Center 97-8, Chicago - Population Research Center.

Articles

  1. Jena Anupam B & Calfee John E. & Mansley Edward C & Philipson Tomas J, 2009. "`Me-Too' Innovation in Pharmaceutical Markets," Forum for Health Economics & Policy, De Gruyter, vol. 12(1), pages 1-21, November.
  2. Tomas J. Philipson & Richard A. Posner, 2009. "Antitrust in the Not-for-Profit Sector," Journal of Law and Economics, University of Chicago Press, vol. 52(1), pages 1-18, 02.
  3. Philipson, Tomas & Berndt, Ernst R. & Gottschalk, Adrian H.B. & Sun, Eric, 2008. "Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts," Journal of Public Economics, Elsevier, vol. 92(5-6), pages 1306-1325, June.
  4. Jena, Anupam B. & Philipson, Tomas J., 2008. "Cost-effectiveness analysis and innovation," Journal of Health Economics, Elsevier, vol. 27(5), pages 1224-1236, September.
  5. Tomas J. Philipson & Richard A. Posner, 2008. "Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy," Journal of Economic Literature, American Economic Association, vol. 46(4), pages 974-82, December.
  6. Tomas J. Philipson & Eric Sun, 2008. "Is the Food And Drug Administration Safe And Effective?," Journal of Economic Perspectives, American Economic Association, vol. 22(1), pages 85-102, Winter.
  7. Tomas Philipson & Anupam B. Jena & Eric Sun, 2007. "The institute of medicine report on the FDA: where is the science?," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 219-221.
  8. Darius Lakdawalla & Tomas Philipson, 2007. "Labor Supply and Weight," Journal of Human Resources, University of Wisconsin Press, vol. 42(1).
  9. Tomas J. Philipson & Dana Goldman, 2007. "Integrated Insurance Design in the Presence of Multiple Medical Technologies," American Economic Review, American Economic Association, vol. 97(2), pages 427-432, May.
  10. Lakdawalla, Darius & Philipson, Tomas, 2006. "The nonprofit sector and industry performance," Journal of Public Economics, Elsevier, vol. 90(8-9), pages 1681-1698, September.
  11. Philipson Tomas J & Jena Anupam B, 2006. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," Forum for Health Economics & Policy, De Gruyter, vol. 9(2), pages 1-33, January.
  12. Darius Lakdawalla & Tomas Philipson & Jay Bhattacharya, 2005. "Welfare-Enhancing Technological Change and the Growth of Obesity," American Economic Review, American Economic Association, vol. 95(2), pages 253-257, May.
  13. Berndt Ernst R. & Gottschalk Adrian H. B. & Philipson Tomas & Strobeck Matthew W., 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," Forum for Health Economics & Policy, De Gruyter, vol. 8(1), pages 1-25, January.
  14. Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares, 2005. "The Quantity and Quality of Life and the Evolution of World Inequality," American Economic Review, American Economic Association, vol. 95(1), pages 277-291, March.
  15. Pierre-Yves Geoffard & Tomas Philipson, 2002. "Pricing and R&D When Consumption Affects Longevity," RAND Journal of Economics, The RAND Corporation, vol. 33(1), pages 85-95, Spring.
  16. Darius Lakdawalla & Tomas Philipson, 2002. "The Rise in Old-Age Longevity and the Market for Long-Term Care," American Economic Review, American Economic Association, vol. 92(1), pages 295-306, March.
  17. Lakdawalla Darius & Philipson Thomas, 2001. "Public Financing and the Market for Long-Term Care," Forum for Health Economics & Policy, De Gruyter, vol. 4(1), pages 1-19, January.
  18. Philipson, Thomas, 2001. "Managed Care and the Quality of Health Care: A Misguided Debate?," The Journal of Legal Studies, University of Chicago Press, vol. 30(2), pages 753-58, June.
  19. Tomas Philipson, 2001. "The world-wide growth in obesity: an economic research agenda," Health Economics, John Wiley & Sons, Ltd., vol. 10(1), pages 1-7.
  20. Philipson, Tomas, 2001. "Data Markets, Missing Data, and Incentive Pay," Econometrica, Econometric Society, vol. 69(4), pages 1099-1111, July.
  21. Tomas Philipson & John Cawley, 1999. "An Empirical Examination of Information Barriers to Trade in Insurance," American Economic Review, American Economic Association, vol. 89(4), pages 827-846, September.
  22. Philipson, Tomas & Malani, Anup, 1999. "Measurement errors: A principal investigator-agent approach," Journal of Econometrics, Elsevier, vol. 91(2), pages 273-298, August.
  23. Tomas J. Philipson & William H. Dow & Xavier Sala-i-Martin, 1999. "Longevity Complementarities under Competing Risks," American Economic Review, American Economic Association, vol. 89(5), pages 1358-1371, December.
  24. Tomas J. Philipson & Gary S. Becker, 1998. "Old-Age Longevity and Mortality-Contingent Claims," Journal of Political Economy, University of Chicago Press, vol. 106(3), pages 551-573, June.
  25. Tomas Philipson & Larry V. Hedges, 1998. "Subject Evaluation in Social Experiments," Econometrica, Econometric Society, vol. 66(2), pages 381-408, March.
  26. Philipson, Tomas & Lawless, Thomas, 1997. "Multiple-output agency incentives in data production: experimental evidence," European Economic Review, Elsevier, vol. 41(3-5), pages 961-970, April.
  27. Geoffard, Pierre-Yves & Philipson, Tomas, 1997. "Disease Eradication: Private versus Public Vaccination," American Economic Review, American Economic Association, vol. 87(1), pages 222-30, March.
  28. Philipson, Tomas, 1997. "The evaluation of new health care technology: The labor economics of statistics," Journal of Econometrics, Elsevier, vol. 76(1-2), pages 375-395.
  29. Philipson, Tomas, 1997. "Data Markets and the Production of Surveys," Review of Economic Studies, Wiley Blackwell, vol. 64(1), pages 47-72, January.
  30. Philipson, Tomas J & Posner, Richard A, 1996. "The Economic Epidemiology of Crime," Journal of Law and Economics, University of Chicago Press, vol. 39(2), pages 405-33, October.
  31. Geoffard, Pierre-Yves & Philipson, Tomas, 1996. "Rational Epidemics and Their Public Control," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 37(3), pages 603-24, August.
  32. Dow, William H. & Philipson, Tomas, 1996. "An empirical examination of the implications of assortative matching on the incidence of HIV," Journal of Health Economics, Elsevier, vol. 15(6), pages 735-749, December.
  33. Philipson, Tomas J & Snyder, James M, Jr, 1996. " Equilibrium and Efficiency in an Organized Vote Market," Public Choice, Springer, vol. 89(3-4), pages 245-65, December.
  34. Philipson, Tomas J & Posner, Richard A, 1995. "A Theoretical and Empirical Investigation of the Effects of Public Health Subsidies for STD Testing," The Quarterly Journal of Economics, MIT Press, vol. 110(2), pages 445-74, May.
  35. Philipson, Tomas, 1995. "The welfare loss of disease and the theory of taxation," Journal of Health Economics, Elsevier, vol. 14(3), pages 387-395, August.
  36. Philipson, Tomas & Posner, Richard A, 1994. "Public Spending on AIDS Education: An Economic Analysis," Journal of Law and Economics, University of Chicago Press, vol. 37(1), pages 17-38, April.
  37. Philipson Tomas, 1993. "Social Welfare and Measurement of Segregation," Journal of Economic Theory, Elsevier, vol. 60(2), pages 322-334, August.
  38. Tomas Philipson, 1991. "Dynamic information release," Journal of Economics, Springer, vol. 53(2), pages 205-213, June.

Chapters

  1. Tomas J. Philipson & Eric Sun & Dana Goldman, 2010. "The Effects of Product Liability Exemption in the Presence of the FDA," NBER Chapters, in: Regulation vs. Litigation: Perspectives from Economics and Law, pages 137-163 National Bureau of Economic Research, Inc.
  2. Anupam B. Jena & John E. Calfee & Edward C. Mansley & Tomas J. Philipson, 2009. ""Me-Too" Innovation in Pharmaceutical Markets," NBER Chapters, in: Frontiers in Health Policy Research, volume 12 National Bureau of Economic Research, Inc.
  3. Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson, 2005. "Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process," NBER Chapters, in: Frontiers in Health Policy Research, Volume 8 National Bureau of Economic Research, Inc.
  4. Anup Malani & Tomas Philipson & Guy David, 2003. "Theories of Firm Behavior in the Nonprofit Sector. A Synthesis and Empirical Evaluation," NBER Chapters, in: The Governance of Not-for-Profit Organizations, pages 181-216 National Bureau of Economic Research, Inc.
  5. Tomas Philipson & Darius Lakdawalla, 2001. "Medical Care Output and Productivity in the Nonprofit Sector," NBER Chapters, in: Medical Care Output and Productivity, pages 119-140 National Bureau of Economic Research, Inc.
  6. Darius Lakdawalla & Thomas Philipson, 2001. "Public Financing and the Market for Long-Term Care," NBER Chapters, in: Frontiers in Health Policy Research, Volume 4, pages 77-94 National Bureau of Economic Research, Inc.
  7. Philipson, Tomas, 2000. "Economic epidemiology and infectious diseases," Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 33, pages 1761-1799 Elsevier.
  8. Tomas Philipson, 2000. "Asymmetric Information and the Not-for-Profit Sector Does Its Output Sell a a Premium?," NBER Chapters, in: The Changing Hospital Industry: Comparing For-Profit and Not-for-Profit Institutions, pages 325-356 National Bureau of Economic Research, Inc.

NEP Fields

35 papers by this author were announced in NEP, and specifically in the following field reports (number of papers):
  1. NEP-AGR: Agricultural Economics (2) 1999-04-27 2007-11-03
  2. NEP-BEC: Business Economics (1) 2013-05-24
  3. NEP-COM: Industrial Competition (2) 2006-04-22 2006-10-21
  4. NEP-CSE: Economics of Strategic Management (1) 2009-06-17
  5. NEP-DEV: Development (1) 2003-06-16
  6. NEP-ENV: Environmental Economics (1) 1999-04-27
  7. NEP-HAP: Economics of Happiness (2) 2008-05-31 2008-07-14
  8. NEP-HEA: Health Economics (23) 1998-09-14 1999-03-01 1999-04-27 2003-06-16 2004-08-31 2004-11-22 2005-11-05 2005-12-09 2005-12-09 2006-01-24 2006-02-26 2007-08-27 2007-11-03 2008-05-31 2008-07-14 2009-12-19 2011-05-14 2012-12-15 2013-05-11 2013-05-24 2013-09-24 2014-05-17 2014-08-02. Author is listed
  9. NEP-IAS: Insurance Economics (4) 2007-02-10 2007-08-27 2007-09-02 2013-05-11
  10. NEP-IND: Industrial Organization (1) 2006-04-22
  11. NEP-INO: Innovation (8) 1999-12-08 2005-12-09 2005-12-09 2006-01-24 2006-02-26 2006-10-21 2011-05-14 2014-05-17. Author is listed
  12. NEP-LAW: Law & Economics (2) 2004-11-22 2006-04-22
  13. NEP-LTV: Unemployment, Inequality & Poverty (2) 2003-06-16 2007-08-27
  14. NEP-MAC: Macroeconomics (1) 2013-05-24
  15. NEP-MKT: Marketing (1) 2006-10-21
  16. NEP-PBE: Public Economics (2) 2005-11-05 2005-12-09
  17. NEP-PKE: Post Keynesian Economics (1) 1999-03-08
  18. NEP-PUB: Public Finance (3) 1998-09-14 2000-05-16 2000-10-31
  19. NEP-REG: Regulation (3) 2005-11-05 2006-04-22 2007-11-03
  20. NEP-SOC: Social Norms & Social Capital (1) 2007-08-27

Statistics

This author is among the top 5% authors according to these criteria:
  1. Average Rank Score
  2. Number of Works
  3. Number of Distinct Works
  4. Number of Distinct Works, Weighted by Simple Impact Factor
  5. Number of Distinct Works, Weighted by Recursive Impact Factor
  6. Number of Distinct Works, Weighted by Number of Authors
  7. Number of Distinct Works, Weighted by Number of Authors and Simple Impact Factors
  8. Number of Distinct Works, Weighted by Number of Authors and Recursive Impact Factors
  9. Number of Citations
  10. Number of Citations, Discounted by Citation Age
  11. Number of Citations, Weighted by Simple Impact Factor
  12. Number of Citations, Weighted by Simple Impact Factor, Discounted by Citation Age
  13. Number of Citations, Weighted by Recursive Impact Factor
  14. Number of Citations, Weighted by Recursive Impact Factor, Discounted by Citation Age
  15. Number of Citations, Weighted by Number of Authors
  16. Number of Citations, Weighted by Number of Authors, Discounted by Citation Age
  17. Number of Citations, Weighted by Number of Authors and Simple Impact Factors
  18. Number of Citations, Weighted by Number of Authors and Simple Impact Factors, Discounted by Citation Age
  19. Number of Citations, Weighted by Number of Authors and Recursive Impact Factors
  20. Number of Citations, Weighted by Number of Authors and Recursive Impact Factors, Discounted by Citation Age
  21. h-index
  22. Number of Registered Citing Authors
  23. Number of Registered Citing Authors, Weighted by Rank (Max. 1 per Author)
  24. Number of Journal Pages, Weighted by Simple Impact Factor
  25. Number of Journal Pages, Weighted by Recursive Impact Factor
  26. Number of Journal Pages, Weighted by Number of Authors and Simple Impact Factors
  27. Number of Journal Pages, Weighted by Number of Authors and Recursive Impact Factors
  28. Number of Abstract Views in RePEc Services over the past 12 months
  29. Closeness measure in co-authorship network
  30. Betweenness measure in co-authorship network
  31. Breadth of citations across fields
  32. Wu-Index

Most cited item

Most downloaded item (past 12 months)

Access and download statistics for all items

Co-authorship network on CollEc

Corrections

For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Tomas Philipson should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.